INSACOG - (Indian SARSCoV2 Genomics Consortium) labs for genome sequencing.
Launched, Coordinated by Department of Biotechnology along with MoH&FW , ICMR, CSIR.
Aim is to monitor the genomic variations in the SARS-CoV-2 on a regular basis through a multi-laboratory network. It is comprising 10 labs namely DBT-NIBMG Kalyani, DBT-ILS Bhubaneswar, ICMR-NIV Pune, DBT-NCCS Pune, CSIR-CCMB Hyderabad, DBT-CDFD Hyderabad, DBT-InSTEM/ NCBS Bengaluru, NIMHANS Bengaluru, CSIR-IGIB Delhi, and NCDC Delhi.
the preliminary study indicates that the variant is unlikely to cause increased risk of reinfection, the new variant might not spread wildly here due to difficulty in finding susceptible persons since 40-50% of urban India particularly in Tier 1 & 2 cities and about 30% people across India would have already been infected.
India has so far sequenced around 6300 genomes of this virus in contrast UK has nearly 157000 genome sequenced even when their cases are around quarter of cases in India.
It will help in boosting India's Defense for this pandemic and make India future prepared. There is a possibility that some virus strain or escape mutant, may change enough to escape the vaccine's immune response as was the case with Hepatitis B.
Comments
Post a Comment